Update In Percutaneous Lung Ablation

  • Seung Wook Ryu
  • Uei PuaEmail author
Chest Imaging ( Section Editor, H Teh)
Part of the following topical collections:
  1. Chest Imaging


Purpose of Review

Radiofrequency ablation has been used over a decade as a treatment option for lung malignancies. More recent devices such as microwave and cryoablation may provide more diverse and improved treatment options, especially in patients with pulmonary oligometastases.

Recent Findings

Percutaneous lung ablations are best suited for medically inoperable patients with small primary lesions or favourably located metastases.


This article provides a review of currently available ablative devices and its use in lung ablation.


Lung cancer Pulmonary metastases Radiofrequency ablation Microwave ablation Cryoablation Irreversible electroporation 


Compliance with Ethical Standards

Conflict of interest

Seung Wook Ryu and Uei Pua declare no potential conflicts of interest.


Papers of particular interest, published recently, have been highlighted as: • Important •• Very important

  1. 1.
    ••Xiong L, Dupuy DE. Lung ablation Whats new? J Thorac Imaging. 2016;31:228–37. Description of available technologies, techniques and outcomes of lung ablation.Google Scholar
  2. 2.
    Alexander ES, Dupuy DE. Lung cancer ablation: technologies and techniques. Semin Intervent Radiol. 2013;30:141–50.CrossRefGoogle Scholar
  3. 3.
    Liu B, Liu L, Hu M, Qian K, Li Y. Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non-small cell lung cancer. Thorac Cancer. 2015;6:327–33.CrossRefGoogle Scholar
  4. 4.
    ••Abtin F, de Baere T, Dupuy DE, Genshaft S, Healey T, Khan S, Suh R. Updates on current role and practice of lung ablation. J Thorac Imaging. 2019;34:266–77. Description of lung ablation techniques, indications and detailed follow up imaging.Google Scholar
  5. 5.
    de Baere T, Tselikas L, Gravel G, Deschamps F. Lung ablation: best practice/results/response assessment/role alongside other ablative therapies. Clin Radiol. 2017;72:657–64.CrossRefGoogle Scholar
  6. 6.
    Skonieczki BD, Wells C, Wasser EJ, Dupuy DE. Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe? Eur J Radiol. 2011;79:343–6.CrossRefGoogle Scholar
  7. 7.
    Sharma A, Abtin F, Shepard JA. Image-guided ablative therapies for lung cancer. Radiol Clin North Am. 2012;50:975–99.CrossRefGoogle Scholar
  8. 8.
    Knavel EM, Hinshaw J, Lubner MG, Andreano A, Warner TF, Lee FT, Brace CL. High-powered gas-cooled microwave ablation: shaft cooling creates an effective stick function without altering the ablation zone. AJR Am J Roentgenol. 2012;198:W260–5.CrossRefGoogle Scholar
  9. 9.
    Lyons GR, Askin G, Pua BB. Clinical outcomes after pulmonary cryoablation with the use of a triple freeze protocol. J Vasc Interv Radiol. 2018;29:714–21.CrossRefGoogle Scholar
  10. 10.
    Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33:223–31.CrossRefGoogle Scholar
  11. 11.
    Ricke J, Jurgens JH, Deschamps F, Tselikas L, Uhde K, Kosiek O, De Baere T. Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial. Cardiovasc Intervent Radiol. 2015;38:401–8.CrossRefGoogle Scholar
  12. 12.
    Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000;355:479–85.CrossRefGoogle Scholar
  13. 13.
    Rami-Porta R, Ball D, Crowley J, Giroux DJ, Jett J, Travis WD, Tsuboi M, Vallieres E, Goldstraw P. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007;2:593–602.CrossRefGoogle Scholar
  14. 14.
    Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth edition lung cancer stage classification. Chest. 2017;151:193–302.CrossRefGoogle Scholar
  15. 15.
    Palussiere J, Chomy F, Savina M, Deschamps F, Gaubert JY, Renault A, Bonnefoy O, Laurent F, Meunier C, Bellera C, Mathoulin-Pelissier S, de Baere T. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial. J Cardiothorac Surg. 2018;13:91.CrossRefGoogle Scholar
  16. 16.
    •Palussiere J, Lagarde P, Auperin A, Deschamps F, Chomy F, de Baere T. Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years’ experience in 87 patients from two centers. Cardiovasc Intervent Radiol. 2015;38:160–6. Prospective multicenter phase II trial evaluating survival outcomes of RFA in patients with inoperable stage 1A NSCLC. CrossRefGoogle Scholar
  17. 17.
    Simon TG, Beland MD, Machan JT, Dipetrillo T, Dupuy DE. Charlson comorbidity index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation. Eur J Radiol. 2012;81:4167–72.CrossRefGoogle Scholar
  18. 18.
    Lencioni R, Crocetti L, Cioni R, Suh R, Glenn D, Regge D, Helmberger T, Gillams AR, Frilling A, Ambrogi M, Bartolozzi C, Mussi A. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9:621–8.CrossRefGoogle Scholar
  19. 19.
    Simon CJ, Dupuy DE, DiPetrillo TA, Safran HP, Grieco CA, Ng T, Mayo-Smith WW. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243:268–75.CrossRefGoogle Scholar
  20. 20.
    Dupuy DE, Fernando HC, Hillman S, Ng T, Tan AD, Sharma A, Rilling WS, Hong K, Putnam JB. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. Cancer. 2015;121:3491–8.CrossRefGoogle Scholar
  21. 21.
    Huang L, Han Y, Zhao J, Wang X, Cheng Q, Li X, Xu H, Gao K. Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies? Eur J Cardiothorac Surg. 2011;39:348–51.CrossRefGoogle Scholar
  22. 22.
    Kodama H, Yamakado K, Takaki H, Kashima M, Uraki J, Nakatsuka A, Takao M, Taguchi O, Yamada T, Takeda K. Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention. Cardiovasc Intervent Radiol. 2012;35:563–9.CrossRefGoogle Scholar
  23. 23.
    Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e278S–313S.CrossRefGoogle Scholar
  24. 24.
    de Baere T, Farouil G, Deschamps F. Lung cancer ablation: what is the evidence? Semin Intervent Radiol. 2013;30:151–6.CrossRefGoogle Scholar
  25. 25.
    Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, Carette MF, Rosenwald JC, Cosset JM, Housset M, Touboul E. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys. 2000;48:1015–24.CrossRefGoogle Scholar
  26. 26.
    de Baere T, Palussiere J, Auperin A, Hakime A, Abdel-Rehim M, Kind M, Dromain C, Ravaud A, Tebboune N, Boige V, Malka D, Lafont C, Ducreux M. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240:587–96.CrossRefGoogle Scholar
  27. 27.
    Wolf FJ, Grand DJ, Machan JT, DiPetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: effectiveness, CT findings and safety in 50 patients. Radiology. 2008;247:871–9.CrossRefGoogle Scholar
  28. 28.
    Yang X, Ye X, Zheng A, Huang G, Ni X, Wang J, Han X, Li W, Wei Z. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol. 2014;110:758–63.CrossRefGoogle Scholar
  29. 29.
    Belfiore G, Ronza F, Belfiore MP, Serao N, di Ronza G, Grassi R, Rotondo A. Patients’ survival in lung malignancies treated by microwave ablation: our experience on 56 patients. Eur J Radiol. 2013;82:177–81.CrossRefGoogle Scholar
  30. 30.
    Healey TT, March BT, Baird G, Dupuy DE. Microwave ablation for lung neoplasms: a retrospective analysis of long-term results. J Vasc Interv Radiol. 2017;28:206–11.CrossRefGoogle Scholar
  31. 31.
    Zhong L, Sun S, Shi J, Cao F, Han X, Bao X, You Q. Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation. J Thorac Dis. 2017;9:590–7.CrossRefGoogle Scholar
  32. 32.
    Moore W, Talati R, Bhattacharji P, Bilfinger T. Five-year survival after cryoablation of Stage I non-small cell lung cancer in medically inoperable patients. J Vasc Interv Radiol. 2015;26:312–9.CrossRefGoogle Scholar
  33. 33.
    Yamauchi Y, Izumi Y, Hashimoto K, Yashiro H, Inoue M, Nakatsuka S, Goto T, Anraku M, Ohtsuka T, Kohno M, Kawamura M, Nomori H. Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer. PLoS ONE. 2012;7:e33223.CrossRefGoogle Scholar
  34. 34.
    Wright JO 3rd, Brandt B 3rd, Ehrenhaft JL. Results of pulmonary resection for metastatic lesions. J Thorac Cardiovasc Surg. 1982;83:94–9.PubMedGoogle Scholar
  35. 35.
    Morrow CE, Vassilopoulos PP, Grage TB. Surgical resection for metastatic neoplasms of the lung: experience at the university of minnesota hospitals. Cancer. 1980;45:2981–5.CrossRefGoogle Scholar
  36. 36.
    McCormack PM, Burt ME, Bains MS, Martini N, Rusch VW, Ginsberg RJ. Lung resection for colorectal metastases 10-year results. Arch Surg. 1992;127:1403–6.CrossRefGoogle Scholar
  37. 37.
    •de Baere T, Auperin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, Fonck M, Escudier B, Palussiere J. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol. 2015;26:987–91. Prospective study evaluating survival and efficacy of RFA for lung metastases.Google Scholar
  38. 38.
    Hiyoshi Y, Miyamoto Y, Kiyozumi Y, Sawayama H, Eto K, Nagai Y, Iwatsuki M, Iwagami S, Baba Y, Yoshida N, Kawanaka K, Yamashita Y, Baba H. CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer. Int J Clin Oncol. 2019;24:288–95.CrossRefGoogle Scholar
  39. 39.
    Vogl TJ, Naguib NN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NE. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology. 2011;261:643–51.CrossRefGoogle Scholar
  40. 40.
    •de Baere T, Tselikas L, Woodrum D, Abtin F, Littrup P, Deschamps F, Suh R, Aoun HD, Callstrom M. Evaluating cryoablation of metastatic lung tumors in patients–safety and efficacy: the ECLIPSE Trial-Interim analysis at 1 Year. J Thorac Oncol. 2015;10:1468–74. Prospective single arm study evaluating early efficacy of cryoablation for lung metastases.CrossRefGoogle Scholar
  41. 41.
    Liu Z, Ahmed M, Weinstein Y, Yi M, Mahajan RL, Goldberg SN. Characterization of the RF ablation-induced ‘oven effect’: the importance of background tissue thermal conductivity on tissue heating. Int J Hyperth. 2006;22:327–42.CrossRefGoogle Scholar
  42. 42.
    Hess A, Palussiere J, Goyers JF, Guth A, Auperin A, de Baere T. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Radiology. 2011;258:635–42.CrossRefGoogle Scholar
  43. 43.
    Palussiere J, Gomez F, Cannella M, Ferron S, Descat E, Fonck M, Brouste V, Avril A. Single-session radiofrequency ablation of bilateral lung metastases. Cardiovasc Interv Radiol. 2012;35:852–9.CrossRefGoogle Scholar
  44. 44.
    Healey TT, Beland MD, Bowkley CW 3rd, Dupuy DE. Stabilization of mobile pulmonary nodules during radiofrequency ablation. AJR Am J Roentgenol. 2010;195:1238–40.CrossRefGoogle Scholar
  45. 45.
    de Baere T, Robinson JM, Rao P, Teriitehau C, Deschamps F. Radiofrequency ablation of lung metastases close to large vessels during vascular occlusion: preliminary experience. J Vasc Interv Radiol. 2011;22:749–54.CrossRefGoogle Scholar
  46. 46.
    Hiraki T, Tajiri N, Mimura H, Yasui K, Gobara H, Mukai T, Hase S, Fujiwara H, Iguchi T, Sano Y, Shimizu N, Kanazawa S. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology. 2006;241:275–83.CrossRefGoogle Scholar
  47. 47.
    Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005;235:289–98.CrossRefGoogle Scholar
  48. 48.
    Nour-Eldin NE, Naguib NN, Mack M, Abskharon JE, Vogl TJ. Pulmonary hemorrhage complicating radiofrequency ablation, from mild hemoptysis to life-threatening pattern. Eur Radiol. 2011;21:197–204.CrossRefGoogle Scholar
  49. 49.
    Sano Y, Kanazawa S, Gobara H, Mukai T, Hiraki T, Hase S, Toyooka S, Aoe M, Date H. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experienc. Cancer. 2007;109:1397–405.CrossRefGoogle Scholar
  50. 50.
    Thornton RH, Solomon SB, Dupuy DE, Bains MS. Phrenic nerve injury resulting from percutaneous ablation of lung malignancy. AJR Am J Roentgenol. 2008;191:565–8.CrossRefGoogle Scholar
  51. 51.
    Hiraki T, Gobara H, Mimura H, Sano Y, Toyooka S, Shibamoto K, Kishi R, Uka M, Kanazawa S. Brachial nerve injury caused by percutaneous radiofrequency ablation of apical lung cancer: a report of four cases. J Vasc Interv Radiol. 2010;2010:1129–33.CrossRefGoogle Scholar
  52. 52.
    Sakurai J, Hiraki T, Mukai T, Mimura H, Yasui K, Gobara H, Hase S, Fujiwara H, Iguchi T, Tajiri N, Aoe M, Sano Y, Date H, Kanazawa S. Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors. J Vasc Interv Radiol. 2007;18:141–5.CrossRefGoogle Scholar
  53. 53.
    Yoshimatsu R, Yamagami T, Terayama K, Matsumoto T, Miura H, Nishimura T. Delayed and recurrent pneumothorax after radiofrequency ablation of lung tumors. Chest. 2009;135:1002–9.CrossRefGoogle Scholar
  54. 54.
    Zhang X, Tian J, Zhao L, Wu B, Kacher DS, Ma X, Liu S, Ren C, Xiao YY. CT-guided conformal cryoablation for peripheral NSCLC: initial experience. Eur J Radiol. 2012;81:3354–62.CrossRefGoogle Scholar
  55. 55.
    Alexander ES, Hankins C, Machan JT, Healey TT, Dupuy DE. Rib fractures after percutaneous radiofrequency and microwave ablation of lung tumors: incidence and relevance. Radiology. 2013;266:971–8.CrossRefGoogle Scholar
  56. 56.
    Okuma T, Matsuoka T, Yamamoto A, Oyama Y, Inoue K, Nakamura K, Inoue Y. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors. J Vasc Interv Radiol. 2007;18:399–404.CrossRefGoogle Scholar
  57. 57.
    Hiraki T, Gobara H, Fujiwara H, Ishii H, Tomita K, Uka M, Makimoto S, Kanazawa S. Lung cancer ablation: complications. Semin Intervent Radiol. 2013;30:169–75.CrossRefGoogle Scholar
  58. 58.
    Eradat J, Abtin F, Gutierrez A, Suh R. Evaluation of treatment response after nonoperative therapy for early-stage non-small cell lung carcinoma. Cancer J. 2011;17:38–48.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Diagnostic RadiologyTan Tock Seng HospitalSingaporeSingapore

Personalised recommendations